Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products
- 31 January 2001
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 59 (1) , 348-357
- https://doi.org/10.1046/j.1523-1755.2001.00497.x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Longitudinal follow-up of CA125 in peritoneal effluentKidney International, 1997
- Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPDKidney International, 1997
- Impact of Terminal Heat Sterilization on the Quality of Peritoneal Dialysis SolutionsBlood Purification, 1997
- Advanced glycation end-products in the peritoneal fluid and in the peritoneal membrane of continuous ambulant peritoneal dialysis patientsNephrology Dialysis Transplantation, 1996
- In vitro formation of advanced glycation end products in peritoneal dialysis fluidKidney International, 1995
- Assessing the peritoneal dialysis capacities of individual patientsKidney International, 1995
- The source and possible significance of hyaluronan in the peritoneal cavityKidney International, 1994
- Computer simulations of peritoneal fluid transport in CAPDKidney International, 1991
- Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929Kidney International, 1991
- Simulations of peritoneal solute transport during CAPD. Application of two-pore formalismKidney International, 1989